FINDMED (https://findmed.fr), through its series of webinars, introduces you to the expertise and technological platforms among the best of the Carnot academic institutes of our consortium and which are accessible to companies in the fields of drugs and health technologies.
In this first FINDMED webinar, we propose to discuss the main expertises and technologies used in medicinal chemistry and screening that may be of interest to VSEs, SMEs and ETIs.
This webinar will be led by Professor Patrick Dallemagne, Director of the Centre d'Etude et de Recherche sur le Médicament de Normandie, part of the Carnot I2C, Vincent Darcos, Head of the Polymers platform of the Carnot Chimie Balard Cirimat, and Marc Lechuga, Head of the Screening platform of the Carnot Voir et Entendre.
They are specialized in drug design, biomolecule synthesis and screening.
The discovery of new active ingredients of therapeutic or diagnostic interest
The evaluation and optimisation of drugability
The operation of chemical libraries
High-Throughput Screening (HTS) in Drug Development
Discovery and optimisation of leads
Characterization of polymers for pharmaceutical use
Custom polymer synthesis
Participation in this webinar is free but subject to registration.
Findmed is a consortium of 10 Carnot institutes, which are French academic research institutions dedicated to setting up collaborative research partnerships with the private sector. industry (from SMEs to international corporations). The objective of Findmed is to facilitate the access of private companies to their expertise and technological resources, so as to contribute to the reinforcement of the medication / drug discovery sector in France.